The headline trial results will be closely monitored by pharmaceutical industry experts. Shares in Novo Nordisk, which ...

The recent volatility in key GLP-1 stocks has put the spotlight on the anxiety Wall Street has about the weight loss market.

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...

Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage ...

A registered dietitian reveals nine food that work like weight-loss drugs, helping to curb cravings and suppress your ...

Over the past year, the question has been coming in from everywhere – from my patients and family members, from colleagues ...

Should you forget Eli Lilly and buy this magnificent biotech instead? Let's find out.

Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, ...

While Novo Nordisk and Lilly are the undisputed leaders in weight management right now, a number of pharmaceutical companies are looking to enter the space. Earlier this month, British pharma leader ...

Scientists from the University of Copenhagen say they have developed a drug that decreases appetite while increasing calorie ...

Analysts chewed over early data showing the highest dose of Amgen’s MariTide was linked to roughly 4% loss of bone mineral ...

The drug is a promising potential competitor in the weight loss drug market that is designed to be taken monthly rather than ...